Back
NeuroBo Pharmaceuticals Stock Price Chart
Write This Down: Tuesday at 2 p.m. ET!
Don't Miss Our LIVE Trade
Sell
19
NRBO
NeuroBo Pharmaceuticals
Last Price:
2.51
Seasonality Move:
-18.3%
7 Day Trial
ALL ACCESS PASS
$
7
Yours Free! Top SIX AI Dividend Stocks Right Now
NO CREDIT CARD REQUIRED!- Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NRBO is experiencing slight selling pressure.
NeuroBo Pharmaceuticals Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 2.71 | Sell |
| 20-day SMA: | 2.72 | Sell |
| 50-day SMA: | 3.11 | Sell |
| 200-day SMA: | 3.94 | Sell |
| 8-day EMA: | 2.68 | Sell |
| 20-day EMA: | 2.78 | Sell |
| 50-day EMA: | 3.08 | Sell |
| 200-day EMA: | 5.03 | Sell |
NeuroBo Pharmaceuticals Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.13 | Sell |
| Relative Strength Index (14 RSI): | 37.53 | Sell |
| Chaikin Money Flow: | -23959 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (2.57 - 2.91) | Sell |
| Bollinger Bands (100): | (2.96 - 4.32) | Sell |
NeuroBo Pharmaceuticals Technical Analysis
| Oct 22 | Oct 23 | Oct 24 | Oct 25 | Oct 28 | Oct 29 | Oct 30 | Oct 31 | Nov 1 | Nov 4 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | Nov | |||||||||
| 22 | 23 | 24 | 25 | 28 | 29 | 30 | 31 | 01 | 04 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for NeuroBo Pharmaceuticals Stock
Is NeuroBo Pharmaceuticals Stock a Buy?
- NeuroBo Pharmaceuticals share price is 2.53 while NRBO 8-day simple moving average is 2.71, which is a Sell signal.
- The stock price of NRBO is 2.53 while NeuroBo Pharmaceuticals 20-day SMA is 2.72, which makes it a Sell.
- NeuroBo Pharmaceuticals 50-day simple moving average is 3.11 while NRBO share price is 2.53, making it a Sell technically.
- NRBO stock price is 2.53 and NeuroBo Pharmaceuticals 200-day simple moving average is 3.94, creating a Sell signal.
NRBO Technical Analysis vs Fundamental Analysis
Sell
19
NeuroBo Pharmaceuticals (NRBO)
is a Sell
Is NeuroBo Pharmaceuticals a Buy or a Sell?
-
NeuroBo Pharmaceuticals stock is rated a Sell
The current NeuroBo Pharmaceuticals [NRBO] share price is $2.53. The Score for NRBO is 19, which is 62% below its historic median score of 50, and infers higher risk than normal.
NeuroBo Pharmaceuticals Stock Info
Market Cap:
21.47M
Price in USD:
2.53
Share Volume:
55.04K
NeuroBo Pharmaceuticals 52-Week Range
52-Week High:
6.75
52-Week Low:
2.08
Sell
19
NeuroBo Pharmaceuticals (NRBO)
is a Sell
NeuroBo Pharmaceuticals Share Price Forecast
-
What is the NeuroBo Pharmaceuticals stock price today?
The NeuroBo Pharmaceuticals stock price is 2.53 USD today. -
Will NRBO stock go up or go down?
NeuroBo Pharmaceuticals> share price is forecast to RISE/FALL based on technical indicators -
Is NeuroBo Pharmaceuticals overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, NeuroBo Pharmaceuticals is overvalued.
Is NeuroBo Pharmaceuticals Stock a Buy?
- NeuroBo Pharmaceuticals share price is 2.53 while NRBO 8-day exponential moving average is 2.68, which is a Sell signal.
- The stock price of NRBO is 2.53 while NeuroBo Pharmaceuticals 20-day EMA is 2.78, which makes it a Sell.
- NeuroBo Pharmaceuticals 50-day exponential moving average is 3.08 while NRBO share price is 2.53, making it a Sell technically.
- NRBO stock price is 2.53 and NeuroBo Pharmaceuticals 200-day simple moving average is 5.03, creating a Sell signal.
Technical Analysis of NeuroBo Pharmaceuticals
Should I short NeuroBo Pharmaceuticals stock?
- NRBO Moving Average Covergence Divergence (MACD) indicator is -0.13, suggesting NeuroBo Pharmaceuticals is a Sell
- NeuroBo Pharmaceuticals Relative Strength Index (RSI) is 37.53, which suggest NeuroBo Pharmaceuticals is oversold
- The Bollinger Bands (25) for NeuroBo Pharmaceuticals is (2.57 - 2.91), which suggest NeuroBo Pharmaceuticals is a Sell
- The Bollinger Bands (100) for NeuroBo Pharmaceuticals is (2.96 - 4.32), which suggest NeuroBo Pharmaceuticals is a Sell
* NeuroBo Pharmaceuticals stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.